Home LiteratureArticle Details
PMID: 18843360 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Malaria research in the post-genomic era.

Nature ·Vol. 455 ·No. 7214 ·2008-10-09 ·Pages 751-6

Winzeler EA

Abstract

For many pathogens the availability of genome sequence, permitting genome-dependent methods of research, can partially substitute for powerful forward genetic methods (genome-independent) that have advanced model organism research for decades. In 2002 the genome sequence of Plasmodium falciparum, the parasite causing the most severe type of human malaria, was completed, eliminating many of the barriers to performing state-of-the-art molecular biological research on malaria parasites. Although new, licensed therapies may not yet have resulted from genome-dependent experiments, they have produced a wealth of new observations about the basic biology of malaria parasites, and it is likely that these will eventually lead to new therapeutic approaches. This review will focus on the basic research discoveries that have depended, in part, on the availability of the Plasmodium genome sequences.

MeSH Terms
Animals Drug Design Genetic Variation/genetics,immunology Genome, Protozoan/genetics Genomics Humans Malaria/drug therapy,epidemiology,parasitology,prevention & control Plasmodium/genetics,immunology,pathogenicity,physiology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Winzeler Elizabeth Ann
Genomics Institute of the Novartis Research Foundation, San Diego, California and The Department of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. [email protected]
References (81)
81 references, click to expand
  1. Targeting malaria virulence and remodeling proteins to the host erythrocyte.
    Science. 2004 Dec 10;306(5703):1930-3 PMID: 15591202
  2. A host-targeting signal in virulence proteins reveals a secretome in malarial infection.
    Science. 2004 Dec 10;306(5703):1934-7 PMID: 15591203
  3. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses.
    Science. 2005 Jan 7;307(5706):82-6 PMID: 15637271
  4. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Nature. 2005 Jan 13;433(7022):164-7 PMID: 15580261
  5. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.
    Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3022-7 PMID: 15699336
  6. The global distribution of clinical episodes of Plasmodium falciparum malaria.
    Nature. 2005 Mar 10;434(7030):214-7 PMID: 15759000
  7. Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum.
    Cell. 2005 Apr 8;121(1):13-24 PMID: 15820675
  8. Effectiveness of antimalarial drugs.
    N Engl J Med. 2005 Apr 14;352(15):1565-77 PMID: 15829537
  9. An ancestral oomycete locus contains late blight avirulence gene Avr3a, encoding a protein that is recognized in the host cytoplasm.
    Proc Natl Acad Sci U S A. 2005 May 24;102(21):7766-71 PMID: 15894622
  10. Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology.
    Cell. 2005 Jun 3;121(5):675-87 PMID: 15935755
  11. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.
    Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12194-9 PMID: 16103357
  12. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes.
    Science. 2005 Aug 26;309(5739):1384-7 PMID: 16123303
  13. A protein interaction network of the malaria parasite Plasmodium falciparum.
    Nature. 2005 Nov 3;438(7064):103-7 PMID: 16267556
  14. High-efficiency transformation of Plasmodium falciparum by the lepidopteran transposable element piggyBac.
    Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16391-6 PMID: 16260745
  15. Microarray-based comparative genomic analyses of the human malaria parasite Plasmodium falciparum using Affymetrix arrays.
    Mol Biochem Parasitol. 2005 Dec;144(2):177-86 PMID: 16174539
  16. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.
    Antimicrob Agents Chemother. 2006 Feb;50(2):480-9 PMID: 16436700
  17. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.
    Mol Microbiol. 2006 Mar;59(5):1369-79 PMID: 16468982
  18. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii.
    Science. 2006 Dec 15;314(5806):1776-80 PMID: 17170305
  19. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.
    J Infect Dis. 2007 Jan 15;195(2):279-87 PMID: 17191173
  20. The genome of the simian and human malaria parasite Plasmodium knowlesi.
    Nature. 2008 Oct 9;455(7214):799-803 PMID: 18843368
  21. The economic and social burden of malaria.
    Nature. 2002 Feb 7;415(6872):680-5 PMID: 11832956
  22. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.
    Nature. 2002 Jul 18;418(6895):320-3 PMID: 12124623
  23. Malaria control with genetically manipulated insect vectors.
    Science. 2002 Oct 4;298(5591):119-21 PMID: 12364786
  24. The genome sequence of the malaria mosquito Anopheles gambiae.
    Science. 2002 Oct 4;298(5591):129-49 PMID: 12364791
  25. A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria.
    Nature. 2006 Feb 23;439(7079):1004-8 PMID: 16382237
  26. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites.
    Genome Biol. 2006;7(2):R12 PMID: 16507167
  27. Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
    Nature. 2006 Apr 13;440(7086):940-3 PMID: 16612385
  28. The malarial host-targeting signal is conserved in the Irish potato famine pathogen.
    PLoS Pathog. 2006 May;2(5):e50 PMID: 16733545
  29. Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production.
    PLoS Pathog. 2006 Mar;2(3):e22 PMID: 16518466
  30. A systematic map of genetic variation in Plasmodium falciparum.
    PLoS Pathog. 2006 Jun;2(6):e57 PMID: 16789840
  31. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes.
    Mol Biochem Parasitol. 2006 Aug;148(2):144-60 PMID: 16644028
  32. A clinical drug library screen identifies astemizole as an antimalarial agent.
    Nat Chem Biol. 2006 Aug;2(8):415-6 PMID: 16816845
  33. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase.
    Nat Methods. 2006 Aug;3(8):615-21 PMID: 16862136
  34. Regulation of sexual development of Plasmodium by translational repression.
    Science. 2006 Aug 4;313(5787):667-9 PMID: 16888139
  35. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.
    Science. 2006 Sep 1;313(5791):1287-90 PMID: 16888102
  36. Genome variation and evolution of the malaria parasite Plasmodium falciparum.
    Nat Genet. 2007 Jan;39(1):120-5 PMID: 17159978
  37. A genome-wide map of diversity in Plasmodium falciparum.
    Nat Genet. 2007 Jan;39(1):113-9 PMID: 17159979
  38. Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome.
    Nat Genet. 2007 Jan;39(1):126-30 PMID: 17159981
  39. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue.
    Nature. 2007 Jan 18;445(7125):324-7 PMID: 17183270
  40. High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
    Antimicrob Agents Chemother. 2007 Feb;51(2):716-23 PMID: 17116676
  41. Cognitive impairment after cerebral malaria in children: a prospective study.
    Pediatrics. 2007 Feb;119(2):e360-6 PMID: 17224457
  42. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.
    J Infect Dis. 2007 Jul 1;196(1):145-54 PMID: 17538895
  43. Malaria vaccines: the stage we are at.
    Nat Rev Microbiol. 2007 Jul;5(7):487-9 PMID: 17571459
  44. Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes.
    Science. 2007 Jun 22;316(5832):1738-43 PMID: 17588928
  45. Mosquito stage, transmission blocking vaccines for malaria.
    Curr Opin Infect Dis. 2007 Oct;20(5):476-81 PMID: 17762780
  46. Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion.
    PLoS Pathog. 2007 Aug 3;3(8):e107 PMID: 17676953
  47. Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family.
    Eukaryot Cell. 2007 Sep;6(9):1511-20 PMID: 17644655
  48. A translocation signal for delivery of oomycete effector proteins into host plant cells.
    Nature. 2007 Nov 1;450(7166):115-8 PMID: 17914356
  49. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.
    Cell. 2007 Nov 2;131(3):492-504 PMID: 17981117
  50. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
    Lancet. 2007 Nov 3;370(9598):1543-51 PMID: 17949807
  51. Distinct physiological states of Plasmodium falciparum in malaria-infected patients.
    Nature. 2007 Dec 13;450(7172):1091-5 PMID: 18046333
  52. A combined transcriptome and proteome survey of malaria parasite liver stages.
    Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):305-10 PMID: 18172196
  53. The decline in paediatric malaria admissions on the coast of Kenya.
    Malar J. 2007;6:151 PMID: 18005422
  54. Genome-wide discovery and verification of novel structured RNAs in Plasmodium falciparum.
    Genome Res. 2008 Feb;18(2):281-92 PMID: 18096748
  55. Evidence-based annotation of the malaria parasite's genome using comparative expression profiling.
    PLoS One. 2008;3(2):e1570 PMID: 18270564
  56. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.
    Emerg Infect Dis. 2008 May;14(5):716-9 PMID: 18439351
  57. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
    PLoS Med. 2008 Jun 17;5(6):e128 PMID: 18563962
  58. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9059-64 PMID: 18579783
  59. Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.
    PLoS Pathog. 2008;4(8):e1000121 PMID: 18688281
  60. Comparative genomics of the neglected human malaria parasite Plasmodium vivax.
    Nature. 2008 Oct 9;455(7214):757-63 PMID: 18843361
  61. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.
    Nature. 2006 Dec 14;444(7121):937-40 PMID: 17151604
  62. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.
    Mol Biochem Parasitol. 2007 Jan;151(1):100-10 PMID: 17125854
  63. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
    Science. 2002 Oct 4;298(5591):210-3 PMID: 12364805
  64. Excess polymorphisms in genes for membrane proteins in Plasmodium falciparum.
    Science. 2002 Oct 4;298(5591):216-8 PMID: 12364807
  65. Genome sequence of the human malaria parasite Plasmodium falciparum.
    Nature. 2002 Oct 3;419(6906):498-511 PMID: 12368864
  66. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii.
    Nature. 2002 Oct 3;419(6906):512-9 PMID: 12368865
  67. A proteomic view of the Plasmodium falciparum life cycle.
    Nature. 2002 Oct 3;419(6906):520-6 PMID: 12368866
  68. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.
    Nature. 2002 Oct 3;419(6906):537-42 PMID: 12368870
  69. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage.
    J Biol Chem. 2002 Nov 1;277(44):41948-53 PMID: 12177071
  70. Early origin and recent expansion of Plasmodium falciparum.
    Science. 2003 Apr 11;300(5617):318-21 PMID: 12690197
  71. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9952-7 PMID: 12886016
  72. Discovery of gene function by expression profiling of the malaria parasite life cycle.
    Science. 2003 Sep 12;301(5639):1503-8 PMID: 12893887
  73. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae.
    Cell. 2004 Mar 5;116(5):661-70 PMID: 15006349
  74. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.
    PLoS Biol. 2003 Oct;1(1):E5 PMID: 12929205
  75. Calcium and a calcium-dependent protein kinase regulate gamete formation and mosquito transmission in a malaria parasite.
    Cell. 2004 May 14;117(4):503-14 PMID: 15137943
  76. A Kazal-like extracellular serine protease inhibitor from Phytophthora infestans targets the tomato pathogenesis-related protease P69B.
    J Biol Chem. 2004 Jun 18;279(25):26370-7 PMID: 15096512
  77. Identification of an antimalarial synthetic trioxolane drug development candidate.
    Nature. 2004 Aug 19;430(7002):900-4 PMID: 15318224
  78. Intercontinental spread of pyrimethamine-resistant malaria.
    Science. 2004 Aug 20;305(5687):1124 PMID: 15326348
  79. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes.
    Nature. 1997 Jan 23;385(6614):336-40 PMID: 9002517
  80. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Science. 1999 Sep 3;285(5433):1573-6 PMID: 10477522
  81. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle.
    Genome Res. 2004 Nov;14(11):2308-18 PMID: 15520293
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2008-10-09
Pages
751-6
Language
English
Region
England
NLM ID
0410462
PMCID
PMC2705782
Subset
IM
Grants
NIAID NIH HHS · R01 AI059472-02 · United States
NIAID NIH HHS · R01 AI059472-04 · United States
NIAID NIH HHS · R01 AI059472 · United States
NIAID NIH HHS · R01 AI059472-03 · United States
NIAID NIH HHS · R01 AI059472-01A2 · United States
NIAID NIH HHS · R01 AI059742 · United States
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]